Literature DB >> 17502107

Inhibition of caspase-2 by a designed ankyrin repeat protein: specificity, structure, and inhibition mechanism.

Andreas Schweizer1, Heidi Roschitzki-Voser, Patrick Amstutz, Christophe Briand, Maya Gulotti-Georgieva, Eva Prenosil, H Kaspar Binz, Guido Capitani, Antonio Baici, Andreas Plückthun, Markus G Grütter.   

Abstract

Specific and potent caspase inhibitors are indispensable for the dissection of the intricate pathways leading to apoptosis. We selected a designed ankyrin repeat protein (DARPin) from a combinatorial library that inhibits caspase-2 in vitro with a subnanomolar inhibition constant and, in contrast to the peptidic caspase inhibitors, with very high specificity for this particular caspase. The crystal structure of this inhibitor (AR_F8) in complex with caspase-2 reveals the molecular basis for the specificity and, together with kinetic analyses, the allosteric mechanism of inhibition. The structure also shows a conformation of the active site that can be exploited for the design of inhibitory compounds. AR_F8 is a specific inhibitor of an initiator caspase and has the potential to help identify the function of caspase-2 in the complex biological apoptotic signaling network.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502107     DOI: 10.1016/j.str.2007.03.014

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  46 in total

1.  A hot-spot motif characterizes the interface between a designed ankyrin-repeat protein and its target ligand.

Authors:  Luthur Siu-Lun Cheung; Manu Kanwar; Marc Ostermeier; Konstantinos Konstantopoulos
Journal:  Biophys J       Date:  2012-02-07       Impact factor: 4.033

2.  Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk.

Authors:  Jie Lin; Charles Lu; David J Stewart; Jian Gu; Maosheng Huang; David W Chang; Scott M Lippman; Xifeng Wu
Journal:  Carcinogenesis       Date:  2012-06-04       Impact factor: 4.944

3.  Phenamacril is a reversible and noncompetitive inhibitor of Fusarium class I myosin.

Authors:  Rasmus D Wollenberg; Manuel H Taft; Sven Giese; Claudia Thiel; Zoltán Balázs; Henriette Giese; Dietmar J Manstein; Teis E Sondergaard
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

Review 4.  Repeat-protein folding: new insights into origins of cooperativity, stability, and topology.

Authors:  Ellen Kloss; Naomi Courtemanche; Doug Barrick
Journal:  Arch Biochem Biophys       Date:  2007-09-15       Impact factor: 4.013

Review 5.  Folding landscapes of ankyrin repeat proteins: experiments meet theory.

Authors:  Doug Barrick; Diego U Ferreiro; Elizabeth A Komives
Journal:  Curr Opin Struct Biol       Date:  2008-02       Impact factor: 6.809

6.  Two-state selection of conformation-specific antibodies.

Authors:  Junjun Gao; Sachdev S Sidhu; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

7.  Toward chaperone-assisted crystallography: protein engineering enhancement of crystal packing and X-ray phasing capabilities of a camelid single-domain antibody (VHH) scaffold.

Authors:  Valentina Tereshko; Serdar Uysal; Akiko Koide; Katrina Margalef; Shohei Koide; Anthony A Kossiakoff
Journal:  Protein Sci       Date:  2008-04-29       Impact factor: 6.725

Review 8.  The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins.

Authors:  Shohei Koide; Sachdev S Sidhu
Journal:  ACS Chem Biol       Date:  2009-05-15       Impact factor: 5.100

9.  Vaccinia Virus Encodes a Novel Inhibitor of Apoptosis That Associates with the Apoptosome.

Authors:  Melissa R Ryerson; Monique M Richards; Marc Kvansakul; Christine J Hawkins; Joanna L Shisler
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

10.  Structural and functional analysis of phosphorylation-specific binders of the kinase ERK from designed ankyrin repeat protein libraries.

Authors:  Lutz Kummer; Petra Parizek; Peter Rube; Bastian Millgramm; Anke Prinz; Peer R E Mittl; Melanie Kaufholz; Bastian Zimmermann; Friedrich W Herberg; Andreas Plückthun
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.